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Summary The relationship between the size of the primary tumour upon initial treatment and the incidence
of distant metastasis during the course of the disease was investigated using data from 2648 breast cancers
treated at the Institut Gustave Roussy between 1954 and 1972. This analysis suggests the existence for each
tumour of a critical volume (threshold) at which the first remote metastasis is initiated. The correlation
between the size of the primary tumour and the probability of metastatic dissemination was assessed as well
as the influence on this correlation of two prognostic indicators: histological grade and number of involved
lymph nodes. It was found that the threshold volume is strongly correlated with the number of involved
lymph nodes and the histological grading.
Until 25 years ago, it was believed that growth of
human tumours was both unpredictable and rapid.
Consequently it was assumed intuitively that the
duration of their apparent life was either short or
consisted of a period of dormancy, of undetermined
duration, followed by rapid growth. Collins et al.,
(1956) were probably the first to study
quantitatively the growth of untreated lung
metastases. They found that during the observation
period, the growth rate, or doubling time (DT), was
constant; in other words, they concluded that
tumour growth followed an exponential function.
This observation had a considerable impact on both
experimental research and clinical thinking. Recent
reviews (Charbit et al., 1971; Steel, 1977; Tubiana,
1982) document numerous investigations during the
past two decades which have shown that, in the
vast majority of human cancer, the growth rate of
the tumour is either constant or progressively
decreasing.
If, indeed, the pattern of growth remains
unchanged throughout, it should be possible to use
a mathematical model of human tumour growth for
two purposes of clinical significance: (i) to
determine the time at which the growth of the
metastasis was initiated and/or the size of the
primary tumour at the time of dissemination; and
(ii) to estimate the size of the occult metastases at
time of the clinical diagnosis (or treatment) of the
primary tumour (Tubiana, 1982). We shall describe
in a subsequent article the mathematical models we
used for this study.
In this paper, we shall consider with respect to
breast cancer, the relationship between the size of
the primary tumour and the dissemination
probability without any assumption about the
pattern of tumour growth.
Patients and methods
Population studied
The population of patients studied included all
cases of invasive breast carcinomas treated at the
Institut Gustave Roussy (IGR) from 1954 to 1972,
excluding the following: male patients, previously-
treated patients, patients with clinical multifocal
tumours and bilateral primary breast cancers, and
patients for whom the diameter of the primary
tumour at diagnosis had not been measured. Thus
2648 patients have been analysed in this study. The
treatment protocol did not change significantly
during the entire period and has been previously
reported (Lacour et al., 1968); in particular
adjuvant chemotherapy was not used.
Data registration
The clinical diameter (D) of the primary tumour
was measured in 2648 cases. The determination of
clinical diameter was done using a semi-quantitative
method before 1958. Clinicians in charge of
classifying tumours recorded the sizes by reference
to a series of mock-objects drawn on a tablet and
used as standards (e.g. egg, cherry, etc.). This
method was similar to that recommended by Okell
(1964) and recognized as valid by Steel (1977). In
1958, this semi-quantitative method was
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transformed using a standard technique, and with
the advice of the clinician by the statistician in
charge of the patient file (e.g. cherry= 1 cm).
Afterwards, a ruler was used to measure the
tumour directly. The tumour volume (V) is
calculated from the diameter using the relation:
V=7rD3/6
For 62% of the patients who had been operated
upon, the size of the tumour was also measured by
the pathologist and registered. The pathological
diameter is therefore available for 911 patients. The
dates concerning the initial treatment, appearance
of the first metastasis, or demise, or most recent
information are known and allow us to calculate
the intervals between the initial treatment and these
various events. Out of 2648 patients we possess
information concerning: the histological grade of
Bloom & Richardson (1957) for 1596 and the
number of involved axillary lymph nodes for 1722.
Percentage ofpatients with distant metastases in
relation to the different clinical diameter values
In order to calculate this proportion, the actuarial
method (Kaplan & Meier 1958) was used to
calculate the curves of the remote metastasis
detection corresponding to the different tumour
diameter values. All patients who died without
metastases are considered as having been
"withdrawn alive" at their time of death for the
purpose of this calculation.
Relationship between tumour volume at the time of
treatment and the probability ofremote metastasis
If we assume the existence of a threshold volume
for each tumour (volume at which the first
metastasis is initiated), then the increase in the
incidence of the metastasis as a function of the
clinical diameter can be interpreted as the
increasing proportion of tumours which are larger
than their threshold volume.
The linearisation of the relationship between the
logarithm of the tumour volume and the
probability of metastasis was studied according to
the technique described by Finney (1964). In
practice, we studied the relationship between the
probits of the estimated percentages of metastases
and the mean value of the logarithms of the tumour
volumes at initial treatment.
Results
Using the actuarial method, we have plotted curves
of metastasis appearance as a time function for a
period of 25 years following primary tumour
treatment. From the overall population, eight
classes have been defined according to the clinical
volume (Table I). It can be seen from these curves
(Figure 1) that the greater the clinical volume, the
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Figure 1 The cumulated proportions of patients with
metastases as a function of the time after treatment in
the different groups of patients defined by the clinical
size of the tumour (see Table I).
Table I Observed and calculated proportions of initiated metastases as a
function of tumour size at the time of treatment.
Proportion ofmetastases
Diameter (from actuarial (from the
Class (cm) curves) lognormal model) No. patients
1 1sD<2.5 0.271 0.240 317
2 2.5<D<3.5 0.420 0.450 496
3 3.5<D<4.5 0.567 0.572 544
4 4.5<D<5.5 0.665 0.664 422
5 5.5<D<6.5 0.728 0.735 329
6 6.5<D<7.5 0.838 0.789 192
7 7.5<D<8.5 0.813 0.829 136
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higher the proportion of metastases at diagnosis
(Ml) and of metastases appearing later during the
course of the disease. Regarding the trend of these
curves, it can be observed that the greater the
clinical volume, the more abrupt the slope of these
curves at their origin. This observation suggests
that the median delay between initial treatment and
appearance of metastases is shorter when the
tumours are large. For example, in patients with
the smallest tumours (class 1), the cumulative
proportion of patients with metastases reached half
its ultimate value 42 months after initial treatment.
In contrast, this proportion is reached after only 4
months for the largest tumours (class 8: tumour
diameter >8.5cm). For all classes, the proportion
of metastases appearing more than 25 post-
treatment years is negligible. We therefore can
assume that, after 25 years, practically all distant
metastases initiated before the primary treatment
have become manifest and that, after this delay, the
proportion of patients with metastases is equal to
the dissemination probability in this subgroup of
patients. Table I shows the percentages of initiated
metastases relevant to the different values ofclinical
volume.
The volume at the time of detection (in
logarithmic coordinates) and the metastasis
initiation probability (in probit coordinates) shows
a remarkable linear relationship (Figure 2). Thus,
the -threshold distribution is lognormal, with a
median of 23.6ml (diameter=3.56cm) and a 95%
confidence range of individual values from 0.14 to
4000ml (the thresholds and the clinical volumes are
assumed independent). The parameters of the
normal distribution allowing us to model the
distribution of the logarithms of the threshold are:
mean=3.16 and standard deviation=2.62. The Chi
square value calculated from the observed effectives
and those calculated from the curve is equal to 1.56
(df=5), which demonstrates a good agreement
between the observations and the lognormal
distribution.
The relationship between the size measured on
the surgical specimen and the dissemination
probability is shown in Figure 3. For the first four
points, this relationship is linear. However, the
proportion of metastases in the fifth group (large
tumours) is below the linear relationship. This
smaller incidence of metastases is probably due to
the selection of the patients referred to the
surgeons, selection which introduces a strong bias,
as most of the patients with large tumours received
pre-operative radiotherapy (Sarrazin et al., 1982). A
similar relationship between size and dissemination
probability is obtained, in the groups of patients for
whom pathological diameter is available, when the
clinical diameter is used instead of the pathological
one. In this case also, the proportion of metastases
in the fifth group is below the linear relationship.
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Figure 2 Relationship between the proportion of
distant metastases and the clinical size of the tumour
in a Log-Probit coordinate system. Size classifications
are as in Table I. The proportions of metastases (±sd)
corresponding to the patients treated during the
periods 1954-1958 (0) and 1959-1972 (x) are plotted
according to the tumour volume. The data concerning
the two periods are pooled for the calculation of the
regression line. The relationship is linear, indicating
that the distribution of the threshold is lognormal.
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Figure 3 Relationship between the proportion of
distant metastases and the size of the tumour
measured on the surgical specimen, in a log-probit
coordinate system.
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The clinical and pathological diameters are
related as shown in Figure 4. This comparison
between the two diameters demonstrates two facts:
First, there is no difference between the patients
treated from 1954-1958 and those treated from
1959-1972; thus, the difference in the methods of
size assessment did not introduce a bias. Second,
for the small tumours, the clinical diameter is
slightly smaller than the pathological one, whereas,
for the large tumours, the clinical diameter is larger
than the pathological one. This overestimation
might be due to an oedema of the skin and of the
tissues surrounding the tumour.
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Figure 5 Relationship between the proportion of
metastases and the clinical size for different groups
defined by the histological grade.
Clinical diameter (cm)
Figure 4 Relationship between the mean clinical and
the mean pathological diameters for the different
classes of tumours defined by clinical diameters,
during the periods 1954-1958 (0) and 1959-1972 (x).
The relationship between the volume at the time
of treatment and the dissemination probability was
analysed as a function of the histological grade
(Figure 5) or the number of axillary lymph nodes
invaded (Figure 6). Regarding the histological
grade, the dissemination probability in grade 1 is
particulary low. There is no significant difference
between tumours of grade 2 and 3. Concerning the
number of involved lymph nodes, the higher their
number, the higher the dissemination probability.
Moreover, as the number of invaded lymph nodes
increases, the threshold volume for initiation of the
metastases decreases. It can be noted that the
curves corresponding to the different numbers of
invaded lymph nodes have slopes which do not
differ significantly. This observation suggests that
the basic mechanism governing the metastasis
probability is the same for the different classes of
tumours.
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Figure 6 Relationship between the proportion of
metastases and the clinical size for different groups
defined by the number of involved lymph nodes.
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Table II Volume (V50) for which 50% of the tumours metastasise, in different groups of
patients.
Median delay between
Corresponding Variation diagnosis and detection
No. VSO diameter interval offirst distant
Group patients (mO (cm) (m) metastasis (months)
Overall 2648 23.6 3.56 19.3-28.8
Histological grade
known (total) 1596 41.0 4.27 30.5-54.8
1 298 584.0 10.4 191-1765 65
2 766 29.5 3.83 19.5-44.7 44
3 532 23.0 3.53 14.6-35.0 21
No. axillary lymph nodes
invaded known
(total) 1722 32.8 3.97 24.5-43.8
0 560 690.0 11.0 217-2180 69
1 to 3 657 30.3 3.87 19.0-48.4 43
>3 505 7.2 2.40 4.0-13.1 30
The different curves (Figures 5 and 6) are in first
approximation parallel. Thus they can be
characterised by their median values. The median
(termed V50) indicates the volume for which 50%
of the tumours have metastasised. The V50 values
for the various groups studied and for the overall.
population are indicated in Table II. For a tumour
of a given size, the dissemination probability is less
if it belongs to a group with a larger V50 value.
The V50 values of three of the groups studied differ
significantly (t test, P<0.001) from those of the
overall population: the group in which the
histological grade is equal to 1, and the group with
no invaded axillary lymph nodes, have a V50 which
is significantly larger than overall; the group with
more than three involved lymph nodes has a V50
which is smaller than for the total population.
These data are consistent with the results of the
analysis of the prognostic factors in this group of
patients (Sarrazin et al., 1982). The possible
relationship between the histological grading and
the number of involved lymph nodes was not taken
into consideration in this paper.
Discussion
This study covers a 19-year period (1954-1972),
and it was therefore important to be sure that no
notable modification in patient classification
procedures had supervened in the meantime (lymph
node involvement and histological grade). The
technique used to assess the histological grade
(Bloom & Richardson, 1957) has not changed since
1958. Concerning the tumours treated before 1958,
the histological specimens were reviewed to classify
them according to Bloom's grading. The
histological technique and the average number of
lymph nodes removed and examined have changed
little with time (Contesso et al., 1977).
The study is based on clinical measurements and
the different classes of tumours are defined at 1 cm
diameter. Such a degree of accuracy can appear
debatable, however the calculations are made on
the mean values of the logarithm of the diameter
and the accuracy of the mean is higher than that of
the individual values. Moreover, changes in the
width of the steps used in classifying the tumour
diameters did not affect the result concerning the
threshold volume distribution. For example, the
slope of the curve and the V50 value of Figure 2
are not modified when the patients are classed with
a 2cm width step in diameter, instead of a 1 cm
step.
Twenty-five percent of the patients were entered
in the study during the period 1954-1958, during
which tumour diameter was not measured directly,
but ascertained by reference to a standard object.
During this period, the cumulative proportion of
patients with metastases is the same as that of the
patients of the period 1959-1972 (Figure 2).
Moreover, during the two periods, the distributions
of tumour volumes are alike, as well as the
relationships between the clinical size and the size
measured on the surgical specimen (Figure 4). This
indicates that the change in the technique of size
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measurement had no significant impact on its
evaluation.
Furthermore, it is well-known that from a
statistical point of view, random inaccuracies in the
measurement of a variable can mask an existing
correlation but cannot create an artefactual
relationship.
Most of the previous studies have been carried
out using the diameter measured on the surgical
specimen because the accuracy of this measurement
was supposed to be greater than that of the volume
assessed clinically. However, this practice introduces
a strong bias in the patient population because the
pathological diameter is available for the patients
selected for surgical treatment without preoperative
radiotherapy. Thus, these patients are not
representative of the overall population; in
particular most of the patients with metastases at
initial presentation are excluded.
However, the information concerning the
histological grade and the number of involved
lymph nodes is available only for the patients
initially treated by surgery, hence the study of the
relation between these variables and the V50 was
studied on a smaller group of patients whose
prognosis was better than average.
Our results are consistent with those reported by
Berg & Robbins (1966). They showed that, among
other factors, the probability of death by cancer
depended, in the long term, on the size of tumours
as measured on the surgical specimen. However,
these authors did not study this relationship
quantitatively and did not attempt to evaluate the
dissemination probability. Moreover, this study was
carried out among a population from which
patients with metastases at diagnosis were excluded.
Such a procedure implies that the patients with
metastases at diagnosis represent a special group,
whereas they only differ from the others by a
slightly greater size of the metastases, which allows
its detection at the same time as the primary
tumour. Nevertheless, we undertook an evaluation
of the V50 in the Berg and Robbins series on the
basis of their data; the V50 which was found
correspond to a tumour diameter of 2.8cm. When
one considers the differences in the patient
populations, there is good concordance with our
own data.
A combined study of the metastasis probability
in relation to tumour size and lymph node invasion
was reported by Fisher et al. (1969). In this study
the follow-up of the patients extended for 5 years
only during which an influence of tumour size on
the dissemination probability was observed. These
results suggested that the influence of mean tumour
size was more pronounced for patients bearing
more than three involved lymph nodes than for
those in the other groups. Our results show that,
regardless of the number of invaded nodes, the
relationship between size and metastasis probability
may be explained by the same model, viz. that the
initiation of the first metastasis occurs when the
tumour volume becomes equal to the threshold
volume. Moreover, the parallelism of the curves
shows that the type of relationship between size and
dissemination probability is the same in the various
groups. The difference between the threshold
volumes of the groups with different histological
grades or number of involved lymph nodes appears
to be due to variations in the probability
dissemination by unit number of cells.
The earlier detection of distant metastases in
patients having several involved lymph nodes
deserves additional discussion. The time interval
between initial treatment and detection of
metastases is influenced by two factors: the growth
rate of the metastasis and the time between
initiation of the metastasis and initial treatment.
These factors have been previously discussed
(Tubiana et al., 1975, 1981a, Tubiana, 1982). As
reported (Tubiana et al., 1975, 1984, Tubiana,
1982) the time interval between relapse and death is
not influenced by the number of involved lymph
nodes which suggests that the growth rates of
metastases are the same regardless of the number of
involved lymph nodes (Tubiana, 1982). Moreover,
the labelling indices of primary breast tumours do
not differ in groups of patients with various
numbers of involved nodes (Tubiana et al., 1981b).
Therefore, it was previously inferred that the earlier
detection of metastases in patients with several
involved lymph nodes was probably due to an
earlier initiation of metastasis, in other words, to a
smaller threshold volume. This idea is supported by
present data which show that the dissemination
probability curves (Figure 5) are almost parallel and
that the median volume (V50) for which 50% of the
tumours have disseminated is smaller in patients
with several involved lymph nodes (Table II).
The differences in the duration of median delay
between diagnosis and detection of metastases
(Table II) provide information of interest. Our data
confirm the prognostic significance of histological
grading (Contesso et al., 1977, Sarrazin et al.,
1982), and stress its influence on the dissemination
probability. They indicate that in the long term, the
distinction between the grades 2 and 3 is not
important, from the point of view of metastasis
probability. However,. the delays between diagnosis
and detection of metastases differ, suggesting a
more rapid growth rate in grade 3 than in grade 2
tumours. This results is in agreement with our
previous measurement of labelling indices (Tubiana
et al., 1981b, 1984).
The estimation of the primary tumour volume at
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fibrosarcomas and seminomas was attempted by
Breur (1976) and in breast cancer by Igot & Le Gal
(1968). The method used consisted of extrapolating
the metastases growth curve backwards in order to
determine at what moment the metastasis contained
one single cell. Though these studies were carried
out on different types of tumours, their results
suggested that metastases are initiated very early in
the life of these tumours, and that the percentage of
metastasis initiated after the tumours reach a
detectable size is very low. These conclusions
conflict with our present data which show that the
primary tumours are relatively large when
metastases are initiated. Moreover they implied that
earlier tumour treatment should result in only a
negligible reduction in the percentage of metastases
(Igot & Le Gal 1968), whereas it has been shown
that, in patients with breast cancers, an early
detection of tumours results in a considerable
decrease of cancer mortality, due to a smaller
metastasis incidence (Strax 1978, Thomas et al.,
1977, Shapiro et al., 1982).
The discrepancy between our data and the above-
mentioned calculations can be attributed to the
hypotheses supporting the previous models. The
main hypotheses underlying those models were: (i)
tumour growth curves are of the exponential type
and (ii) the growth rate of a tumour and its
metastases are equal. Present knowledge concerning
the pattern of human tumour growth do not
warrant these hypotheses. In particular, the
doubling times of primary tumours are on the
whole longer than those of metastases (Charbit et
al., 1971; Steel 1977). Thus, the discrepancy
between our data and the results obtained by the
backwards extrapolation of the metastases growth
curve might be explained by the inadequacy of the
model used. This will be further discussed in a
subsequent article.
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